Jazz Pharmaceuticals plc (NASDAQ: JAZZ) today announced that Anne O'Riordan, Senior Managing Director, Life Sciences of Accenture, was appointed to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Management Changes Management Comments

Jazz Pharmaceuticals Announces Appointment of Anne O'Riordan to its Board of DirectorsFebruary 14, 2019 4:05 PM Viking Global's 13F Shows New Stakes in Adobe (ADBE), American Airlines (AAL), Boeing (BA), Zillow (ZG), Increase in Alibaba (BABA) (More...)February 14, 2019 10:09 AM Jazz Pharmaceuticals (JAZZ) PT Lowered to $175 at Oppenheimer as Erwinaze Deal TerminatedFebruary 12, 2019 12:26 PM Jazz Pharmaceuticals (JAZZ) PT Lowered to $185 at Cantor FitzgeraldFebruary 12, 2019 11:54 AM